These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2887951

  • 1. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output.
    Nubiola-Calonge P, Badía JM, Sancho J, Gil MJ, Segura M, Sitges-Serra A.
    Lancet; 1987 Sep 19; 2(8560):672-4. PubMed ID: 2887951
    [Abstract] [Full Text] [Related]

  • 2. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.
    Nubiola P, Badia JM, Martinez-Rodenas F, Gil MJ, Segura M, Sancho J, Sitges-Serra A.
    Ann Surg; 1989 Jul 19; 210(1):56-8. PubMed ID: 2500900
    [Abstract] [Full Text] [Related]

  • 3. [Value of octreotide in the treatment of postoperative enterocutaneous fistula].
    Sleth JC, Andraos Y, Borie F, Dumay R, Legroux P.
    Ann Fr Anesth Reanim; 1994 Jul 19; 13(5):738-40. PubMed ID: 7733526
    [Abstract] [Full Text] [Related]

  • 4. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Sancho JJ, di Costanzo J, Nubiola P, Larrad A, Beguiristain A, Roqueta F, Franch G, Oliva A, Gubern JM, Sitges-Serra A.
    Br J Surg; 1995 May 19; 82(5):638-41. PubMed ID: 7613936
    [Abstract] [Full Text] [Related]

  • 5. Treatment of gastrointestinal fistulas with Sandostatin.
    Sitges-Serra A, Guirao X, Pereira JA, Nubiola P.
    Digestion; 1993 May 19; 54 Suppl 1():38-40. PubMed ID: 8359567
    [Abstract] [Full Text] [Related]

  • 6. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M, Ahmed U, Sobia H.
    J Coll Physicians Surg Pak; 2004 Apr 19; 14(4):237-40. PubMed ID: 15228830
    [Abstract] [Full Text] [Related]

  • 7. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child.
    Ohlbaum P, Galperine RI, Demarquez JL, Vergnes P, Martin C.
    J Pediatr Gastroenterol Nutr; 1987 Apr 19; 6(3):466-70. PubMed ID: 2892904
    [Abstract] [Full Text] [Related]

  • 8. Role of octreotide and somatostatin in the treatment of intestinal fistulae.
    Dorta G.
    Digestion; 1999 Apr 19; 60 Suppl 2():53-6. PubMed ID: 10207232
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of hypersecretory ileostomy, gastrostomy and fistula of the small intestine with the somatostatin analog octreotide].
    Lindsetmo RO, Revhaug A.
    Tidsskr Nor Laegeforen; 1994 Oct 10; 114(24):2829-30. PubMed ID: 7998027
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V, Felekis D, Zorbalas A.
    Hepatogastroenterology; 2002 Oct 10; 49(46):1010-2. PubMed ID: 12143189
    [Abstract] [Full Text] [Related]

  • 11. Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995.
    Wallace AM, Newman K.
    J Pediatr Surg; 1991 Sep 10; 26(9):1097-100. PubMed ID: 1941488
    [Abstract] [Full Text] [Related]

  • 12. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.
    Kocak S, Bumin C, Karayalcin K, Alacayir I, Aribal D.
    Dig Dis; 1994 Sep 10; 12(1):62-8. PubMed ID: 8200125
    [Abstract] [Full Text] [Related]

  • 13. Small bowel fistulas treated with somatostatin: preliminary results.
    Geerdsen JP, Pedersen VM, Kjaergård HK.
    Surgery; 1986 Nov 10; 100(5):811-4. PubMed ID: 2877506
    [Abstract] [Full Text] [Related]

  • 14. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
    Scott NA, Finnegan S, Irving MH.
    Acta Gastroenterol Belg; 1993 Nov 10; 56(3-4):266-70. PubMed ID: 8266769
    [Abstract] [Full Text] [Related]

  • 15. [Closure of postoperative anastomotic fistulas with a somatostatin analogue].
    Niv Y, Hadari A, Asaf V, Oren M.
    Harefuah; 1991 Jun 02; 120(11):647-8. PubMed ID: 1937211
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
    Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM.
    Can J Gastroenterol; 2004 May 02; 18(5):303-6. PubMed ID: 15152279
    [Abstract] [Full Text] [Related]

  • 17. [Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)].
    Gerardo Pérez D, Bernardo Acosta M.
    G E N; 1994 May 02; 48(4):209-18. PubMed ID: 7557275
    [Abstract] [Full Text] [Related]

  • 18. Octreotide and gastrointestinal fistulae.
    Scott NA, Finnegan S, Irving MH.
    Digestion; 1990 May 02; 45 Suppl 1():66-70; discussion 70-1. PubMed ID: 2185968
    [Abstract] [Full Text] [Related]

  • 19. [The somatostatin analog SMA (201-995) as adjuvant treatment in patients with external fistulae of the digestive system].
    Castañón González JA, Miranda Ruíz R, Arías E, Fuentes Pintado E, Zárate Treviño A.
    Gac Med Mex; 1992 May 02; 128(3):285-8. PubMed ID: 1302733
    [Abstract] [Full Text] [Related]

  • 20. Severe hyperglycemia following transition from octreotide to lanreotide in a patient with enterocutaneous fistula receiving parenteral nutrition.
    Rosen AN, Balazh JR, Franck AJ.
    Nutr Clin Pract; 2022 Jun 02; 37(3):727-731. PubMed ID: 34462966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.